Year: 2013
Type: article
Abstract: With the aim of fuelling open-source, translational, early-stage drug discovery activities, the results of the recently completed antimycobacterial phenotypic screening campaign against Mycobacterium bovis BCG with hit confirmation in M. tuberculosis H37Rv were made publicly accessible. A set of 177 potent non-cytotoxic H37Rv hits was identified and will be made available to maximize the potential impact of the compounds toward a chemical genetics/proteomics exercise, while at the same time providing a plethora of potential starting points for new synthetic lead-generation activities. Two additional drug-discovery-relevant datasets are included: a) a drug-like property analysis reflecting the latest lead-like guidelines and b) an early lead-generation package of the most promising hits within the clusters identified.
Source: ChemMedChem
Authors: Lluís Ballell, Robert H. Bates, Rob J. Young, Daniel Alvarez‐Gomez, Emilio Alvarez‐Ruiz, Vanessa Barroso, Delia Blanco, Benigno Crespo, Jaime Escribano, Rubén González, Sonia Lozano, Sophie Huss, Angel Santos‐Villarejo, José Julio Martín‐Plaza, Alfonso Mendoza, María José Rebollo‐Lopez, Modesto Remuiñan‐Blanco, José Luis Lavandera, Esther Pérez‐Herran, Francisco Javier Gamo‐Benito, José Francisco García‐Bustos, David Barros, Julia P. Castro, Nicholas Cammack
Institutions: GlaxoSmithKline (Spain), GlaxoSmithKline (United Kingdom)
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2034080889
